SCHEMBL19785950

SCHEMBL19785950

C=Cc1c[nH]c(=O)c(C(=O)Nc2cccc(Cl)c2C#N)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.45
TAS1R1 Q7RTX1 1/20 0.45
TAS1R2 Q8TE23 1/20 0.45
KDR P35968 3/20 0.39
CASP3 P42574 2/20 0.36
HPGD P15428 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
KDM4E B2RXH2 3/20 0.36
MAPT P10636 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
MEN1 O00255 1/20 0.36
APAF1 O14727 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
THRB P10828 1/20 0.36
CASP1 P29466 1/20 0.36
HTT P42858 1/20 0.36
RECQL P46063 1/20 0.36
BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19785829 0.90 TAS1R3 (0.46) TAS1R3TAS1R1TAS1R2KDRCASP3
SCHEMBL19785982 0.84 KDR (0.55) TAS1R3TAS1R1TAS1R2KDRCASP3
SCHEMBL19785763 0.81 KDR (0.37) TAS1R3TAS1R1TAS1R2KDRBTK
SCHEMBL19779431 0.79 TAS1R3 (0.43) TAS1R3TAS1R1TAS1R2CASP3HPGD
SCHEMBL19785768 0.77 PDCD1 (0.43) TAS1R3TAS1R1TAS1R2KDRMEN1
SCHEMBL19785953 0.75 KDR (0.45) KDRCASP3KDM4EL3MBTL1MEN1
SCHEMBL396661 0.74 CFTR (0.63) MEN1KMT2ACFTR
SCHEMBL19785758 0.72 KDR (0.43) KDRKDM4EMAPTL3MBTL1ALDH1A1
SCHEMBL19779672 0.72 TAS1R3 (0.47) TAS1R3TAS1R1TAS1R2HPGDCYP1A2
SCHEMBL19785949 0.69 TAS1R3 (0.38) TAS1R3TAS1R1TAS1R2CASP3HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018013789-A1 HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS INCYTE CORPORATION (US) 2018-01-18 WO disclosed